INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2011

A review summarizes human pharmacokinetic and pharmacodynamic data for resveratrol, noting a lack of clinical evidence and conflicting capsule versus food data.

This review examines nutrapharmacology and the therapeutic potential of resveratrol, a polyphenol found in grape skins and other plants, for targeting aging and obesity-related chronic diseases. It evaluates laboratory findings on inflammation and oxidative stress alongside published human pharmacokinetic and pharmacodynamic data. The authors note key obstacles to clinical use, including a lack of clinical evidence to date, a myriad of available doses and formulations, conflicting data on capsules versus food forms, and uncertain effects of long-term dosing.

Study type
Narrative review
Who was studied
Published human pharmacokinetic and pharmacodynamic data
What was measured
Human pharmacokinetic and pharmacodynamic data of resveratrol

THE PAPER

Resveratrol--pills to replace a healthy diet?

Chachay VS, Kirkpatrick CM, Hickman IJ, Ferguson M, Prins JB, Martin JH. Br J Clin Pharmacol, 2011.

PubMed 21410504 ↗DOI 10.1016/j.numecd.2010.03.003 ↗

CancerWeight & appetiteHealthy aging & longevityOther healthTop 21: Grapes

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.